Shintaro Saito

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)

Yasuhiro Nakamura, Kenjiro Namikawa, Shusuke Yoshikawa et al. · ESMO Open · 2021 · 57 citations · Full text

Medicine, Immunology, Oncology +17

Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients

Yasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa et al. · European Journal of Cancer · 2022 · 44 citations

Medicine, Immunology, Oncology +17

Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study

Yoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa et al. · European Journal of Cancer · 2021 · 41 citations

Medicine, Immunology, Oncology +16

Successful treatment of Raynaud's phenomenon and digital ulcers in systemic sclerosis patients with botulinum toxin B injection: Assessment of peripheral vascular disorder by angiography and dermoscopic image of nail fold capillary

Sei‐ichiro Motegi, Akiko Sekiguchi, Shintaro Saito et al. · The Journal of Dermatology · 2017 · 28 citations

Medicine, Dermatology, Pharmacotherapy +16

Synthesis of l-α-phosphatidyl-d-myo-inositol 3,5-bisphosphate from d-glucose

Asuka Nishikawa, Shintaro Saito, Yuichi Hashimoto et al. · Tetrahedron Letters · 2001 · 27 citations

Life Sciences, Biochemistry, Cell Biology +4